Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

New Safety Information: Rituxan (Rituximab) and Progressive Multifocal Leukoencephalopathy (PML)
Genentech has added new information to the prescribing information for Rituxan (rituximab), a medication used to treat Non-Hodgkin's Lymphoma and Rheumatoid Arthritis. The prescribing information now warns that progressive multifocal leukoencephalopathy (PML), a life threatening disease of the brain, can occur in patients who receive Rituxan. For more information please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109106.htm
Learn More

TNF Blockers Increase the Risk of Fungal Infections
The FDA recently released an alert to remind patients that tumor necrosis factor-alpha blockers (TNF blockers), such as ETANERCEPT (ENBREL), may increase your risk for infections. This can include serious infections caused by viruses, fungi, or bacteria, including tuberculosis (TB). The FDA is especially concerned that serious fungal infections are not being recognized in patients taking TNF blockers and that this may result in delays in the correct treatment. For more information please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109340.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2008-09-12 New Safety Information: Rituxan (Rituximab) and Progressive Multifocal Leukoencephalopathy (PML) Rituximab Manufacturer
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Etanercept FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Certolizumab FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Adalimumab FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Infliximab FDA
2008-09-03 Mix-ups between regular insulin U-100 and insulin U-500 Insulin FDA
2008-09-03 Statins plus fibrates increase risk of muscle problems Simvastatin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Lovastatin and Niacin MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Clofibrate MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Fenofibrate MediGuard CRT
2008-09-03 Statins plus fibrates increase risk of muscle problems Gemfibrozil MediGuard CRT
2008-08-26 Two new cases of progressive multifocal leukoencephalopathy (PML) Natalizumab FDA
2008-08-26 Several lots of DAYTRANA (methylphenidate transdermal system) voluntarily recalled Methylphenidate Manufacturer
2008-08-22 FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin Ezetimibe with Simvastatin FDA
2008-08-22 FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin Ezetimibe FDA
2008-08-21 Inhaled insulin Exubera no longer available after September 1, 2008 Manufacturer
2008-08-21 Drug Shortage Manufacturer
2008-08-21 Illegal Botox Scammers Onabotulinumtoxina FDA
2008-08-18 Update on potential for acute pancreatitis in patients using Byetta Exenatide FDA